AnaSpec will be adding a one pound box of See’s Candy into every order placed from now through the end of the year. - November 29, 2007 - AnaSpec, Inc.

In an in vivo 'Proof of Concept' study, Samaritan Pharmaceuticals, Inc. has confirmed Caprospinol's (SP-233) efficacy in its ability to dramatically decrease beta amyloid plaque in the brain, accompanied by a complete recovery of memory back to baseline (p=0.002), as shown in a Morris water maze task. This study confirms previously reported in vitro data and suggests Caprospinol may not only slow the progress of Alzheimer's, but may also reverse plaque-related brain injuries associated with AD. - November 27, 2007 - Samaritan Pharmaceuticals

AnaSpec introduces a new collection of secondary antibodies and streptavidin labeled with the new HiLytePlus™ series of fluorescent dyes. - November 17, 2007 - AnaSpec, Inc.

Karoline Cerin-Stepic of Victoria, Australia has won her division at the recent Asia-Pacific Bodybuilding Championships. Karoline competed against almost 50 other women in the figure division, and took out first place in the tall class. She attributes much of her success to the IAPC Natural Bodybuilding... - November 11, 2007 - Ironpower

Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirteen (13) new catalog peptides. Bak BH3 (71-89)- Cat# 62261 This peptide is amino acids 71 to 89 fragment of the Bak BH3 domain .The BH3 domain plays a critical role in mediating the cell death and... - November 11, 2007 - AnaSpec, Inc.

Bio-Synthesis is expanding Dye Labeling Licensing - November 09, 2007 - Bio-Synthesis Inc. - Premium Press Release

This week AnaSpec announced the release of the HiLytePlus™ series of fluorescent dyes. Demonstrating even greater brightness than AnaSpec’s HiLyte Fluor™ line, this series represents the next generation in AnaSpec’s line of high performance fluorescent dyes. With excitation wavelengths... - November 09, 2007 - AnaSpec, Inc.

Re-orders are on the rise for a new liquid energy shot energy drink product from Indianapolis-based DMD Pharmaceuticals. The company attributes the on-line spike in re-orders for the EPHRINE Plus® Energy Shot to new national print advertising, as well as the product delivering on its promise of convenience, portability, and a rapid-release energy-boosting formula promoted as “more kick, less can.” - November 03, 2007 - DMD Pharmaceuticals

Dr. Steve Bannister’s expertise requested for several speaking engagements over the next year - October 31, 2007 - Xcelience, LLC

NCSRT Introduces WORKS™, an integrated program of products, applications guides, optimization tools, and services to dramatically improve downstream processing in the biopharmaceutical production environment. With the patented SmartFlow™ TFF modules and industry leading PUROSEP® filtration... - October 30, 2007 - NCSRT, Inc.

As the colder months approach and the growing season for many varieties of fresh fruit is over, finding fresh fruit is getting more difficult. However, research indicates that the antioxidant benefits of fresh fruit should be enjoyed year round. - October 30, 2007 - Fruit Advantage

24 year old Jaslyn Hewitt, tennis star Lleyton Hewitt’s younger sister, has qualified to compete in the International Natural Bodybuilding Association (INBA) Australian Bodybuilding titles after only 6 months of entering the sport. Jaslyn trained for several hours a day to prepare for the state... - October 26, 2007 - Ironpower

AnaSpec has introduced two new catalog antibodies: Anti-Keratin-18 and Anti-Keratin-19. Intermediate filaments (IFs), together with actin microfilaments and tubulin microtubules, comprise the three major cytoskeletal networks that are found in most eukaryotic cells.1 Keratins, which are the largest... - October 24, 2007 - AnaSpec, Inc.

Leveraging its dual expertise in peptides and detection reagents, AnaSpec has released c[RGDyK(HiLyte FluorTM 750)], a labeled RGD peptide that has produced significant imaging results in a recent in vivo research study. Extracellular matrix proteins containing the Arg-Gly-Asp (RGD) motif, and integrin... - October 18, 2007 - AnaSpec, Inc.

Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced one new unusual amino acid and two new catalog peptides. HRP Prorenin; Decoy Handle Region Peptide- Cat# 62118 Sequence: RILLKKMPSV Fmoc-HomoArg(Pbf)-OH- Cat# 60004-1/ 60004-5 TP508; Thrombin-derived... - October 17, 2007 - AnaSpec, Inc.

In a comparison study between schizophrenia treatments INVEGA™ (paliperidone) Extended-Release Tablets and SEROQUEL® (quetiapine), Invega patients saw schizophrenia symptom improvements as early as five days into therapy and continued through the end of the two-week study period. Results were presented today at the 20th Annual U.S. Psychiatric and Mental Health Congress in Orlando, Florida. - October 13, 2007 - Johnson & Johnson

Acne Therapy Lotion Aims to Prevent Future Breakouts and Repair Acne-Stressed Skin with High-Performance Ingredients - October 12, 2007 - MenScience Androceuticals

AnaSpec introduces its newest offering – the SensoLyte™ Homogeneous AFC Caspase-8 Assay Kit - October 11, 2007 - AnaSpec, Inc.

Learn how to get the natural health benefits and daily suggested allowance of fruit year round. - October 09, 2007 - Fruit Advantage

AnaSpec has introduced Smart Search, an optimized site search engine for locating items in AnaSpec’s expansive collection of products. - October 07, 2007 - AnaSpec, Inc.

AnaSpec has introduced two new catalog antibodies: Anti-Keratin-18 and Anti-Keratin-19. Intermediate filaments (IFs), together with actin microfilaments and tubulin microtubules, comprise the three major cytoskeletal networks that are found in most eukaryotic cells.1 Keratins, which are the largest... - October 06, 2007 - AnaSpec, Inc.

AnaSpec introduced fifteen (15) new peptides for drug discovery research. - October 04, 2007 - AnaSpec, Inc.

Samaritan announced today the appointment of James E.K. Hildreth, M.D., a world renowned physician and HIV researcher, to its Scientific Advisory Board. The work of Dr. Hildreth in HIV/AIDS dates back to 1986 and focuses on blocking HIV infection by learning how HIV gets into cells. He has published more than 80 scientific articles and holds six patents. - October 03, 2007 - Samaritan Pharmaceuticals

AnaSpec, one of the world’s leading providers of dye-labeled and FRET (fluorescent resonance energy transfer) peptides, has introduced a collection of dye-labeled amino acids and resins. Already conjugated with fluorescent dyes or quencher molecules, these ready-to-use building blocks eliminate... - September 27, 2007 - AnaSpec, Inc.

AnaSpec introduced nine (9) new peptides for drug discovery research - September 26, 2007 - AnaSpec, Inc.

Ex-Wall Street Professional is now selling tart cherry juice and tart cherry capsules. - September 26, 2007 - Fruit Advantage

Fresh, antioxidant-rich fruit is abundant during the warm summer months, however with cooler fall weather approaching fresh fruit is more difficult to find. Fruit Advantage has solved this seasonal dilemma. - September 25, 2007 - Fruit Advantage

Continuing in its commitment to expand its antibody offerings, AnaSpec added nine (9) new antibodies to its growing collection of catalog antibodies. Anti-Estrogen Receptor-alpha (Paired 167) - Cat# 28002, 50 µg Host: rabbit polyclonal; Species Reactivity: human; monkey; chimpanzees; Applications:... - September 23, 2007 - AnaSpec, Inc.

Caryn Jones of Victoria, Australia has become the first student to gain a perfect 100% score of the Bodybuilding Contest Preparation certificate course run by the International Academy of Physique Conditioning (IAPC) - http://iapc.us It is the world's first bodybuilding contest preparation certification... - September 22, 2007 - Ironpower

AnaSpec has introduced its newest collection of Anti-LC antibodies that can be used as autophagosome markers. - September 21, 2007 - AnaSpec, Inc.

New probiotic supplement developed by a Texas gastroenterologist with more than 25 years in practice. Supplement contains 6 billion active bacteria to promote gastrointestinal health, wellness. - September 19, 2007 - EndoMune Probiotic

Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirty-two (32) new peptides for drug discovery research. - September 16, 2007 - AnaSpec, Inc.

With its reported relation to cardiovascular disease, kidney disease, and severe acute respiratory syndrome (SARS), Angiotensin I converting enzyme 2 (ACE2) has become an increasingly important therapeutic target. - September 12, 2007 - AnaSpec, Inc.

BioHealthRx, a fast growing medical job board for the biotechnology, healthcare, and pharmaceutical industries, has announced their partnership with JobTarget, an industry leader in job board development and management, to partner in the JobTarget OneClick Network. By utilizing the OneClick technology,... - September 10, 2007 - BioHealthRx

Dr. Roger Kenneth Hershline PhD MD, Chairman and Founder of CureHIV.us, agreed to provide samples of Global Humanceuticals, Inc’s NIAID#11039, a new powerful class of anti-HIV drug to clinical researchers. The drug is able de-activates the virus even if diluted nearly a billion times. - September 09, 2007 - CureHIV - Featured Press Release

Reinforcing the quality presented by ZMC’s fermentation technology CoQ10, ZMC commissioned several toxicology studies performed by The Institute of Environmental Toxicology located in Ibaraki, Japan. The tests confirmed that ZMC’s coenzyme Q10 is safe at high doses. - September 07, 2007 - ZMC-USA

AnaSpec, the key supplier of kinase peptide libraries mentioned in the articles, has announced the worldwide commercial availability of its newest kinase peptide library. - September 07, 2007 - AnaSpec, Inc.

Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced fifty-five (55) new peptides for drug discovery research. - September 05, 2007 - AnaSpec, Inc.

Confidential, Convenient and Affordable Lab Testing - August 30, 2007 - Personalized Lab Services, LLC

Leveraging its expertise in both detection reagents and antibodies, AnaSpec has introduced a new series of labeled Anti-CD-3ε and anti-CD79α antibodies. - August 29, 2007 - AnaSpec, Inc.

Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirty-six (36) new peptides for drug discovery research. Protease-Activated Receptor-4; PAR-4 Agonist; amide; human Amyloid Precursor Protein (APP) (667-676); Swedish mutation Colivelin AGA-(C8R) HNG17;... - August 28, 2007 - AnaSpec, Inc.

This week AnaSpec introduced the SensoLyteTM 520 TACE Assay Kit, offering fluorescence detection at the industry’s longest wavelengths. With higher fluorescence quantum yield and longer emission wavelength, this kit shows less autofluorescence interference from test compounds and cellular components,... - August 28, 2007 - AnaSpec, Inc.

As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 500. - August 26, 2007 - AnaSpec, Inc.

Paradise Promotions Ltd., a Canadian corporation that manufactures and distributes a government approved herbal-based, smoking cessation aid across Canada, is preparing to launch the medicine into the United States marketplace. - August 25, 2007 - Paradise Promotions Ltd.

Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added ten (10) new antibodies to its growing collection of catalog antibodies. Anti-MAP1-LC3 beta (NT) - Cat# 29783, 50 µg Host:rabbit polyclonal; Species Rectivity:Human;... - August 25, 2007 - AnaSpec, Inc.

One of the world’s largest providers of catalog peptides, AnaSpec introduced its CEF Control Peptide Pool. Previously available only individually, this group of peptides is now available pooled. The CEF Control Peptide Pool is a group of 32 peptides, 8-12 amino acids in length, with sequences... - August 23, 2007 - AnaSpec, Inc.

Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added twenty-eight (28) new antibodies to its growing collection of catalog antibodies. - August 22, 2007 - AnaSpec, Inc.

Samaritan announced that it has entered into an exclusive licensing agreement with Georgetown University for a patent covering the Peripheral Benzodiazepine Receptor (PBR) which has led to Cancer drug candidates with the ability to inhibit cancerous tumors; and an imaging technique that could possibly distinguish cancerous tumors for a more targeted and improved chemotherapy. - August 21, 2007 - Samaritan Pharmaceuticals

As every recruiter knows, manually posting jobs is a tedious time consuming process. BioHealthRx, a fast growing medical job board, has recently partnered with SmartPost to assist in the elimination of such tasks. SmartPost is a leading job posting distribution service owned by Bernard Hodes Group,... - August 20, 2007 - BioHealthRx

One of the world’s largest providers of unusual amino acids, today AnaSpec announced the release of its 2007-2009 Combinatorial Chemistry catalog. - August 18, 2007 - AnaSpec, Inc.